Thursday 30 January

Please note that this is the preliminary programme; times and titles are still subject to change.

 08.30 - 9:00                  Plenary III - Seeding assays for alphasynuclein
                                         Alison Green (Edinburgh, UK)

09.00 - 09.30                Plenary IV - Co-pathology in DLB
                                         David Irwin (Pennsylvania, USA)

09.30 - 09.45               SHORT BREAK

09.45 - 11.15                     Symposium IV - Fluid biomarkers
                                         Chairs: Charlotte Teunissen & Brit Mollenhauer  

Oral presentations:
Katharina Bolsewig - DOPA Decarboxylase: High discriminative power in CSF, but confounded by treatment in blood
Jodi Maple-Grødem - Predicting Dementia in Parkinson’s Disease: Insights from α-Synuclein SAA, NfL, Aβ, and GCase Biomarkers
Carla Abdelnour - Diagnostic accuracy of plasma biomarkers for detecting amyloidosis in alpha-synucleinopathies
Elena Vera Campuzano - Differential Associations of plasma NfL and Cognitive Performance in Lewy Bodies Disease Patients with and without Alzheimer’s Disease Co-Pathology
James Leverenz - The US Dementia with Lewy Bodies Consortium: Description and Insights on the Performance of CSF Synuclein Aggregation Assay

11.15 - 11.45                    COFFEE Break

11.45 - 13.15                      Symposium V - Imaging/neurophysiology biomarkers
                                          Chairs: Dani Ferreira & Laura Bonnani

Oral presentations:
Christina Tremblay - Prediction of phenoconversion in isolated REM sleep behavior disorder using free water imaging: a longitudinal, multicentre, prospective cohort study
Matej Perovnik - The dementia with Lewy bodies related metabolic brain pattern expression in patients with dementia with Lewy bodies, Alzheimer dementia and Parkinson disease dementia: a multicentric study
Angeliki Zarkali - Glymphatic dysfunction contributes to development of cognitive impairment in Parkinson’s independently from white matter degeneration
Bastiaan GJ Tol - Pathways for the progression of neurodegeneration in dementia with Lewy bodies
Anita D'Anselmo - Increased functional coupling of EEG pre-alpha rhythms in patients with Dementia with Lewy Bodies

13.15 - 14.30                   LUNCH/Poster session

14.30 - 16.00                   Symposium VI - Biological classification and DLB

          • NSD-ISS
            Tatyana Simuni  (Chicago, USA)
          • SyNeurGe
            Anthony Lang (Toronto, Canada)

          • ATN-classification, lessons learned from Alzheimer’s disease
            Philip Scheltens (Amsterdam, NL)

          • Biological classification from DLB perspective
            Bradley Boeve (Minnesota, USA)

16.00-16.30                    BREAK

16.30-17.30                       Panel discussion
                                           "How is Lewy body dementia related to other
                                         neurodegenerative disorders” 
                                            Chairs: John-Paul Taylor & Jim Leverenz